Suppr超能文献

镰状细胞病成人无症状性脑梗死的分布。

Distribution of Silent Cerebral Infarcts in Adults With Sickle Cell Disease.

机构信息

From the Departments of Pediatrics (R.S.J., C.B., S.D.), Vanderbilt University Medical Center, Nashville, TN; Neurology (A.L.F., S.F., R.C.), Washington University, St. Louis, MO; Neurology (M.J.D.); Radiology (L.T.D., S.P.); Vanderbilt-Meharry Center of Excellence in Sickle Cell Disease (M.R.D.); Medicine (A.A.K.), Vanderbilt University Medical Center, Nashville, TN; Rodeghier Consulting (M.R.), Chicago, IL; Pediatrics, Neurology and Radiology (L.C.J.), Vanderbilt University Medical Center, Nashville, TN.

出版信息

Neurology. 2024 May;102(10):e209247. doi: 10.1212/WNL.0000000000209247. Epub 2024 Apr 29.

Abstract

BACKGROUND AND OBJECTIVES

Previously we demonstrated that 90% of infarcts in children with sickle cell anemia occur in the border zone regions of cerebral blood flow (CBF). We tested the hypothesis that adults with sickle cell disease (SCD) have silent cerebral infarcts (SCIs) in the border zone regions, with a secondary hypothesis that older age and traditional stroke risk factors would be associated with infarct occurrence in regions outside the border zones.

METHODS

Adults with SCD 18-50 years of age were enrolled in a cross-sectional study at 2 centers and completed a 3T brain MRI. Participants with a history of overt stroke were excluded. Infarct masks were manually delineated on T2-fluid-attenuated inversion-recovery MRI and registered to the Montreal Neurological Institute 152 brain atlas to generate an infarct heatmap. Border zone regions between anterior, middle, and posterior cerebral arteries (ACA, MCA, and PCA) were quantified using the Digital 3D Brain MRI Arterial Territories Atlas, and logistic regression was applied to identify relationships between infarct distribution, demographics, and stroke risk factors.

RESULTS

Of 113 participants with SCD (median age 26.1 years, interquartile range [IQR] 21.6-31.4 years, 51% male), 56 (49.6%) had SCIs. Participants had a median of 5.5 infarcts (IQR 3.2-13.8). Analysis of infarct distribution showed that 350 of 644 infarcts (54.3%) were in 4 border zones of CBF and 294 (45.6%) were in non-border zone territories. More than 90% of infarcts were in 3 regions: the non-border zone ACA and MCA territories and the ACA-MCA border zone. Logistic regression showed that older participants have an increased chance of infarcts in the MCA territory (odds ratio [OR] 1.08; 95% CI 1.03-1.13; = 0.001) and a decreased chance of infarcts in the ACA-MCA border zone (OR 0.94; 95% CI 0.90-0.97; < 0.001). The presence of at least 1 stroke risk factor did not predict SCI location in any model.

DISCUSSION

When compared with children with SCD, in adults with SCD, older age is associated with expanded zones of tissue infarction that stretch beyond the traditional border zones of CBF, with more than 45% of infarcts in non-border zone regions.

摘要

背景与目的

此前我们发现,镰状细胞贫血患儿的 90%梗死发生在脑血流(CBF)的边缘区。我们验证了这样一个假说,即镰状细胞病(SCD)成年患者在边缘区存在无症状性脑梗死(SCI),并有一个次要假说,即年龄较大和传统的卒中危险因素与边缘区以外的梗死发生相关。

方法

在两个中心进行了一项横断面研究,纳入了年龄在 18-50 岁的 SCD 成年患者,并完成了 3T 脑 MRI 检查。排除有显性卒中病史的患者。在 T2 液体衰减反转恢复 MRI 上手动勾画梗死灶,并将其注册到蒙特利尔神经学研究所 152 脑图谱,以生成梗死热图。使用数字 3D 脑 MRI 动脉区域图谱量化前、中、后大脑动脉(ACA、MCA 和 PCA)之间的边缘区,并应用逻辑回归来确定梗死分布、人口统计学和卒中危险因素之间的关系。

结果

在 113 名 SCD 患者(中位年龄 26.1 岁,四分位间距[IQR] 21.6-31.4 岁,51%为男性)中,56 名(49.6%)患者存在 SCI。患者的中位梗死数量为 5.5 个(IQR 3.2-13.8)。分析梗死分布显示,644 个梗死灶中有 350 个(54.3%)位于 4 个 CBF 边缘区,294 个(45.6%)位于非边缘区。超过 90%的梗死发生在 3 个区域:非边缘区 ACA 和 MCA 区以及 ACA-MCA 边缘区。逻辑回归显示,年龄较大的患者 MCA 区梗死的几率增加(比值比[OR] 1.08;95%置信区间[CI] 1.03-1.13; = 0.001),而 ACA-MCA 边缘区梗死的几率降低(OR 0.94;95%CI 0.90-0.97; < 0.001)。在任何模型中,至少存在 1 个卒中危险因素与 SCI 部位均无相关性。

讨论

与 SCD 患儿相比,SCD 成年患者中,年龄较大与超出传统 CBF 边缘区的组织梗死区扩张有关,超过 45%的梗死发生在非边缘区。

相似文献

1
Distribution of Silent Cerebral Infarcts in Adults With Sickle Cell Disease.
Neurology. 2024 May;102(10):e209247. doi: 10.1212/WNL.0000000000209247. Epub 2024 Apr 29.
2
Interventions for preventing silent cerebral infarcts in people with sickle cell disease.
Cochrane Database Syst Rev. 2017 May 13;5(5):CD012389. doi: 10.1002/14651858.CD012389.pub2.
3
Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.
Cochrane Database Syst Rev. 2017 Jan 17;1(1):CD003146. doi: 10.1002/14651858.CD003146.pub3.
4
Association of Cerebral Hemodynamics and Anemia on Processing Speed in Adults with Sickle Cell Disease.
J Neurol Exp Neural Sci. 2023;5(1). doi: 10.29011/2577-1442.100050. Epub 2023 Jul 24.
5
Cerebral Oxygen Metabolic Stress in Children and Adults With Large Vessel Vasculopathy Due to Sickle Cell Disease.
Neurology. 2024 Dec 10;103(11):e210032. doi: 10.1212/WNL.0000000000210032. Epub 2024 Nov 15.
6
Quantifying dilated perivascular spaces in children with sickle cell disease.
Pediatr Blood Cancer. 2024 Sep;71(9):e31150. doi: 10.1002/pbc.31150. Epub 2024 Jul 2.
8
Cerebral Hemodynamic Responses to Disease-Modifying and Curative Sickle Cell Disease Therapies.
Neurology. 2025 Jan 14;104(1):e210191. doi: 10.1212/WNL.0000000000210191. Epub 2024 Dec 20.
9
Folate supplementation in people with sickle cell disease.
Cochrane Database Syst Rev. 2018 Mar 16;3(3):CD011130. doi: 10.1002/14651858.CD011130.pub3.
10
Laser therapy for retinopathy in sickle cell disease.
Cochrane Database Syst Rev. 2022 Dec 12;12(12):CD010790. doi: 10.1002/14651858.CD010790.pub3.

引用本文的文献

1
Comparison of Asymptomatic Brain Lesions Between Thalassemia Major and Sickle Cell Anemia Patients.
Medicina (Kaunas). 2025 Jan 19;61(1):159. doi: 10.3390/medicina61010159.
2
Chronic active lesions preferentially localize in watershed territories in multiple sclerosis.
Ann Clin Transl Neurol. 2024 Nov;11(11):2912-2922. doi: 10.1002/acn3.52202. Epub 2024 Oct 24.
3
Watershed regions are more susceptible to tissue microstructural injury in multiple sclerosis.
Brain Commun. 2024 Sep 3;6(5):fcae299. doi: 10.1093/braincomms/fcae299. eCollection 2024.
4
Stroke Prevention and Treatment for Youth with Sickle Cell Anemia: Current Practice and Challenges and Promises for the Future.
Curr Neurol Neurosci Rep. 2024 Nov;24(11):537-546. doi: 10.1007/s11910-024-01372-9. Epub 2024 Sep 21.
5
Silent Cerebral Infarcts in Adults With Sickle Cell Disease: Expanding Beyond Childhood Borders.
Neurology. 2024 May;102(10):e209319. doi: 10.1212/WNL.0000000000209319. Epub 2024 Apr 29.

本文引用的文献

2
Cerebral hemodynamics and oxygenation in adult patients with sickle cell disease after stem cell transplantation.
Am J Hematol. 2024 Feb;99(2):163-171. doi: 10.1002/ajh.27135. Epub 2023 Oct 19.
3
Evidence-based interventions for reducing sickle cell disease-associated morbidity and mortality in sub-Saharan Africa: A scoping review.
SAGE Open Med. 2023 Sep 15;11:20503121231197866. doi: 10.1177/20503121231197866. eCollection 2023.
4
Digital 3D Brain MRI Arterial Territories Atlas.
Sci Data. 2023 Feb 4;10(1):74. doi: 10.1038/s41597-022-01923-0.
5
Assessment of functional shunting in patients with sickle cell disease.
Haematologica. 2022 Nov 1;107(11):2708-2719. doi: 10.3324/haematol.2021.280183.
6
Longitudinal Changes in Global Cerebral Blood Flow in Cognitively Normal Older Adults: A Phase-Contrast MRI Study.
J Magn Reson Imaging. 2022 Nov;56(5):1538-1545. doi: 10.1002/jmri.28133. Epub 2022 Feb 26.
7
Sickle cell disease as an accelerated aging syndrome.
Exp Biol Med (Maywood). 2022 Feb;247(4):368-374. doi: 10.1177/15353702211068522. Epub 2022 Feb 16.
8
Low Rates of Cerebral Infarction after Hematopoietic Stem Cell Transplantation in Patients with Sickle Cell Disease at High Risk for Stroke.
Transplant Cell Ther. 2021 Dec;27(12):1018.e1-1018.e9. doi: 10.1016/j.jtct.2021.08.026. Epub 2021 Sep 13.
9
Trends in Sickle Cell Disease-Related Mortality in the United States, 1979 to 2017.
Ann Emerg Med. 2020 Sep;76(3S):S28-S36. doi: 10.1016/j.annemergmed.2020.08.009.
10
Reduced oxygen extraction efficiency in sickle cell anemia patients with evidence of cerebral capillary shunting.
J Cereb Blood Flow Metab. 2021 Mar;41(3):546-560. doi: 10.1177/0271678X20913123. Epub 2020 Apr 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验